<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p161" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_161{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_161{left:799px;bottom:1132px;letter-spacing:-0.08px;}
#t3_161{left:162px;bottom:1067px;letter-spacing:0.11px;word-spacing:1.5px;}
#t4_161{left:162px;bottom:1050px;letter-spacing:0.12px;word-spacing:3.49px;}
#t5_161{left:162px;bottom:1032px;letter-spacing:0.11px;word-spacing:2.44px;}
#t6_161{left:162px;bottom:1015px;letter-spacing:0.11px;word-spacing:3.95px;}
#t7_161{left:162px;bottom:997px;letter-spacing:0.11px;word-spacing:1px;}
#t8_161{left:162px;bottom:979px;letter-spacing:0.1px;word-spacing:0.02px;}
#t9_161{left:162px;bottom:962px;letter-spacing:0.12px;word-spacing:1.26px;}
#ta_161{left:162px;bottom:944px;letter-spacing:0.12px;word-spacing:2.4px;}
#tb_161{left:162px;bottom:927px;letter-spacing:0.11px;word-spacing:0.72px;}
#tc_161{left:162px;bottom:909px;letter-spacing:0.11px;word-spacing:-0.19px;}
#td_161{left:162px;bottom:892px;letter-spacing:0.11px;word-spacing:1.53px;}
#te_161{left:162px;bottom:874px;letter-spacing:0.1px;word-spacing:-0.59px;}
#tf_161{left:162px;bottom:857px;letter-spacing:0.11px;word-spacing:0.91px;}
#tg_161{left:162px;bottom:839px;letter-spacing:0.11px;word-spacing:2.96px;}
#th_161{left:162px;bottom:821px;letter-spacing:0.11px;word-spacing:1.66px;}
#ti_161{left:162px;bottom:804px;letter-spacing:0.1px;word-spacing:0.02px;}
#tj_161{left:162px;bottom:786px;letter-spacing:0.12px;word-spacing:2.2px;}
#tk_161{left:162px;bottom:769px;letter-spacing:0.11px;word-spacing:0.02px;}
#tl_161{left:141px;bottom:721px;letter-spacing:0.14px;}
#tm_161{left:162px;bottom:700px;letter-spacing:0.14px;}
#tn_161{left:162px;bottom:665px;letter-spacing:0.14px;word-spacing:0.03px;}
#to_161{left:255px;bottom:673px;letter-spacing:-0.03px;}
#tp_161{left:271px;bottom:665px;}
#tq_161{left:279px;bottom:665px;letter-spacing:0.13px;word-spacing:0.03px;}
#tr_161{left:357px;bottom:673px;}
#ts_161{left:365px;bottom:665px;letter-spacing:0.12px;word-spacing:0.04px;}
#tt_161{left:479px;bottom:673px;}
#tu_161{left:162px;bottom:656px;}
#tv_161{left:167px;bottom:648px;letter-spacing:0.12px;word-spacing:0.9px;}
#tw_161{left:468px;bottom:648px;}
#tx_161{left:478px;bottom:656px;}
#ty_161{left:483px;bottom:648px;letter-spacing:0.11px;word-spacing:0.9px;}
#tz_161{left:162px;bottom:630px;letter-spacing:0.11px;word-spacing:0.03px;}
#t10_161{left:162px;bottom:595px;letter-spacing:0.15px;}
#t11_161{left:243px;bottom:595px;letter-spacing:0.11px;word-spacing:0.76px;}
#t12_161{left:162px;bottom:577px;letter-spacing:0.11px;word-spacing:1.77px;}
#t13_161{left:162px;bottom:560px;letter-spacing:0.11px;word-spacing:-0.01px;}
#t14_161{left:162px;bottom:542px;letter-spacing:0.1px;word-spacing:0.03px;}
#t15_161{left:162px;bottom:524px;letter-spacing:0.14px;}
#t16_161{left:223px;bottom:524px;letter-spacing:0.11px;word-spacing:0.39px;}
#t17_161{left:162px;bottom:507px;letter-spacing:0.11px;word-spacing:0.39px;}
#t18_161{left:162px;bottom:489px;letter-spacing:0.11px;word-spacing:0.75px;}
#t19_161{left:162px;bottom:472px;letter-spacing:0.1px;word-spacing:0.15px;}
#t1a_161{left:399px;bottom:472px;letter-spacing:0.1px;word-spacing:0.13px;}
#t1b_161{left:452px;bottom:472px;letter-spacing:0.11px;word-spacing:0.15px;}
#t1c_161{left:162px;bottom:454px;letter-spacing:0.1px;word-spacing:0.02px;}
#t1d_161{left:162px;bottom:437px;letter-spacing:0.1px;}
#t1e_161{left:213px;bottom:437px;letter-spacing:0.11px;word-spacing:0.35px;}
#t1f_161{left:162px;bottom:419px;letter-spacing:0.11px;word-spacing:-0.19px;}
#t1g_161{left:162px;bottom:402px;letter-spacing:0.11px;word-spacing:0.93px;}
#t1h_161{left:162px;bottom:384px;letter-spacing:0.11px;word-spacing:0.64px;}
#t1i_161{left:162px;bottom:366px;letter-spacing:0.09px;word-spacing:0.02px;}
#t1j_161{left:162px;bottom:349px;letter-spacing:0.11px;}
#t1k_161{left:249px;bottom:349px;letter-spacing:0.11px;word-spacing:0.41px;}
#t1l_161{left:162px;bottom:331px;letter-spacing:0.1px;word-spacing:0.16px;}
#t1m_161{left:162px;bottom:314px;letter-spacing:0.1px;word-spacing:0.02px;}
#t1n_161{left:141px;bottom:257px;letter-spacing:0.15px;}
#t1o_161{left:162px;bottom:236px;letter-spacing:0.15px;}
#t1p_161{left:162px;bottom:201px;letter-spacing:0.12px;word-spacing:0.03px;}
#t1q_161{left:302px;bottom:201px;letter-spacing:0.12px;word-spacing:0.03px;}
#t1r_161{left:162px;bottom:184px;letter-spacing:0.11px;word-spacing:0.06px;}
#t1s_161{left:162px;bottom:166px;letter-spacing:0.1px;}
#t1t_161{left:162px;bottom:131px;letter-spacing:0.12px;}
#t1u_161{left:252px;bottom:131px;letter-spacing:0.11px;word-spacing:0.48px;}
#t1v_161{left:162px;bottom:113px;letter-spacing:0.12px;word-spacing:0.33px;}
#t1w_161{left:162px;bottom:96px;letter-spacing:0.11px;word-spacing:-0.04px;}
#t1x_161{left:162px;bottom:78px;letter-spacing:0.11px;word-spacing:0.02px;}

.s0_161{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_161{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_161{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s3_161{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s4_161{font-size:10px;font-family:TimesNewRomanPS-BoldMT_8j;color:#000;}
.s5_161{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
.s6_161{font-size:15px;font-family:TimesNewRomanPS-ItalicMT_8n;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts161" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_8j;
	src: url("fonts/TimesNewRomanPS-BoldMT_8j.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-ItalicMT_8n;
	src: url("fonts/TimesNewRomanPS-ItalicMT_8n.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg161Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg161" style="-webkit-user-select: none;"><object width="935" height="1210" data="161/161.svg" type="image/svg+xml" id="pdf161" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_161" class="t s0_161">Brain: Chemistry to Cognition </span><span id="t2_161" class="t s1_161">153 </span>
<span id="t3_161" class="t s0_161">Metabolic homeostasis regulates many biological functions, and its deregulation is responsible for severe </span>
<span id="t4_161" class="t s0_161">pathophysiological conditions such as obesity and diabetes. Regulated exocytosis is an important cell </span>
<span id="t5_161" class="t s0_161">physiological process during which dense-core vesicles (DCV) release cargo in response to an external </span>
<span id="t6_161" class="t s0_161">stimulus. However, the effect of obesity-induced metabolic stress on regulated secretion isstill being </span>
<span id="t7_161" class="t s0_161">determined. We modelled obesity-associated metabolic stress by feeding the mice with a high-fat diet and </span>
<span id="t8_161" class="t s0_161">glucose tolerance test (GTT) was used to validate the obesity model. </span>
<span id="t9_161" class="t s0_161">We then used Neuropeptide-Y (NPY)-pHluorin imaging in primary chromaffin cells to discover impaired </span>
<span id="ta_161" class="t s0_161">stimulus-coupled regulated secretion in obese animals. To further study which modes of exocytosis are </span>
<span id="tb_161" class="t s0_161">affected by metabolic stress, we used Tetramethylrhodamine (TMR)-dextran staining and interestingly, we </span>
<span id="tc_161" class="t s0_161">found a significant reduction in 40kDa dextran (full fusion) staining in obese chromaffin cells. We next used </span>
<span id="td_161" class="t s0_161">electron microscopy (EM) and found a significant increase in the dense core diameter of DCVs in obese </span>
<span id="te_161" class="t s0_161">chromaffin cells compared to control cells indicating a possible maturation defect caused by metabolic stress. </span>
<span id="tf_161" class="t s0_161">Similar findings were documented in primary pancreatic islets. To understand the molecular determinants, </span>
<span id="tg_161" class="t s0_161">we have conducted the transcriptomic analysis in chromaffin and pancreatic islets to discover specific </span>
<span id="th_161" class="t s0_161">pathways and genes associated with trafficking getting differentially expressed. We are in the process of </span>
<span id="ti_161" class="t s0_161">validating some of those candidates using our cell culture systems. </span>
<span id="tj_161" class="t s0_161">In summary, we show that HFD-induced metabolic stress leads to a defect in DCVs maturation and an </span>
<span id="tk_161" class="t s0_161">impediment in stimulus-coupled regulated exocytosis in chromaffin cells and primary islets. </span>
<span id="tl_161" class="t s2_161">P132: Molecular docking and simulation studies for identifying binding affinity of </span>
<span id="tm_161" class="t s2_161">flavonoids for α7nAChR for the treatment of Alzheimer’s disease </span>
<span id="tn_161" class="t s3_161">Sushma Singh </span>
<span id="to_161" class="t s4_161">a, b </span>
<span id="tp_161" class="t s3_161">, </span><span id="tq_161" class="t s0_161">Ahsas Goyal </span>
<span id="tr_161" class="t s5_161">b </span>
<span id="ts_161" class="t s0_161">and Neetu Agrawa </span>
<span id="tt_161" class="t s5_161">b </span>
<span id="tu_161" class="t s5_161">a </span>
<span id="tv_161" class="t s0_161">Pharmacy college, Azamgarh-276128, UP, India</span><span id="tw_161" class="t s3_161">; </span>
<span id="tx_161" class="t s4_161">b </span>
<span id="ty_161" class="t s0_161">Institute of Pharmaceutical Research, GLA University, </span>
<span id="tz_161" class="t s0_161">Mathura-281406, UP, India </span>
<span id="t10_161" class="t s3_161">Background</span><span id="t11_161" class="t s0_161">: Alpha-7-nicotinic acetylcholine receptor (α7nAChR) is one of the ligand-gated ion channels </span>
<span id="t12_161" class="t s0_161">and one of the essential parts of the cholinergic pathway in the brain and thus it plays important role in </span>
<span id="t13_161" class="t s0_161">Alzheimer’s disease (AD). It has been reported that α7nAChR regulation by the phytoconstituent plays vital </span>
<span id="t14_161" class="t s0_161">role in the treatment of AD. </span>
<span id="t15_161" class="t s3_161">Method: </span><span id="t16_161" class="t s0_161">Fifty flavonoids were evaluated for the binding efficacy for human α7nAChR by using molecular </span>
<span id="t17_161" class="t s0_161">docking. On the basis of their binding efficacy best two flavonoids were selected from docking results then </span>
<span id="t18_161" class="t s0_161">after molecular dynamic simulations for 100 ns for binding stability analysis with the α7nAChRwere done </span>
<span id="t19_161" class="t s0_161">of two selected flavonoids. Then after </span><span id="t1a_161" class="t s6_161">in silico </span><span id="t1b_161" class="t s0_161">ADMET studies were performed to check the drug ability of </span>
<span id="t1c_161" class="t s0_161">the selected flavonoids. </span>
<span id="t1d_161" class="t s3_161">Result: </span><span id="t1e_161" class="t s0_161">Amentoflavone (–9.1 kcal/mol) and gallocatechin (–8.8 kcal/mol) were the two selected flavonoids </span>
<span id="t1f_161" class="t s0_161">which has best binding efficacy with the α7nAChR. The molecular dynamics simulation studies showed that </span>
<span id="t1g_161" class="t s0_161">both amentoflavone and gallocatechin were at stable state during duration of simulation period, root mean </span>
<span id="t1h_161" class="t s0_161">square deviation (RMSD) and root mean square fluctuation (RMSF), and protein flavonoids complex were </span>
<span id="t1i_161" class="t s0_161">stable until 100 ns. </span>
<span id="t1j_161" class="t s3_161">Conclusion: </span><span id="t1k_161" class="t s0_161">Amentoflavone and gallocatechin are potential lead molecules that could be used as effective </span>
<span id="t1l_161" class="t s0_161">agonists of α7nAChR to treat Alzheimer’s disease. Thus, to confirm their effectiveness in future invitro and </span>
<span id="t1m_161" class="t s0_161">in-vivo analysis can be done. </span>
<span id="t1n_161" class="t s2_161">P133: NLRP3 and NLRP12 play distinct cell-specific roles in innate immune Cross-talk </span>
<span id="t1o_161" class="t s2_161">in Glioblastoma Pathophysiology </span>
<span id="t1p_161" class="t s3_161">Sushmita Rajkhowa, </span><span id="t1q_161" class="t s0_161">Durgesh Meena, and Sushmita Jha </span>
<span id="t1r_161" class="t s0_161">Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan- </span>
<span id="t1s_161" class="t s0_161">342037. </span>
<span id="t1t_161" class="t s3_161">Background: </span><span id="t1u_161" class="t s0_161">Glioblastoma (GBM), are malignant gliomas with poor survival. Nucleotide-binding domain </span>
<span id="t1v_161" class="t s0_161">LRR-containing receptor (NLR) family proteins NLRP3 and NLRP12 regulate inflammation and immunity </span>
<span id="t1w_161" class="t s0_161">and are known to play reciprocal roles with cell-specific tumour-promoting or anti-tumor functions. We aim </span>
<span id="t1x_161" class="t s0_161">to understand NLRP3 and NLRP12 differential expression and function in GBM pathophysiology. </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
